A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemia.
Cancer Sci
; 111(9): 3327-3337, 2020 Sep.
Article
in En
| MEDLINE
| ID: mdl-32639651
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pyrimidines
/
Waldenstrom Macroglobulinemia
/
Protein Kinase Inhibitors
/
Imidazoles
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Sci
Year:
2020
Type:
Article
Affiliation country:
Japan